Annlouise Assaf, MS, PhD
Annlouise Assaf, MS, PhD, is a Pfizer Senior Director and Patient Health Activation Expert in Worldwide Medical and Safety on the Global Medical Impact Assessment team. In this role, she partners to evolve the science and practice of benefit risk to inform better drug development, healthcare decisions, and outcomes for patients. Dr. Assaf joined Pfizer in 2002 after many years in academic medicine and clinical research at Brown Medical School. She received her PhD in Experimental Pathology/Epidemiology and her MS in Natural Sciences (immunology) from the Roswell Park Cancer Institute (RPCI) at the State University of New York at Buffalo.